Trials / Withdrawn
WithdrawnNCT00755989
Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds
A Phase 3, Single-centered, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Trial of Morphine Sulfate Gel 0.1% in Patients With Stage 2-3 Wounds
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Banner Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.
Detailed description
Patients will be randomized to receive either placebo (versa base gel) or morphine gel to wound. Patients receiving morphine gel will have a decrease in pain score and use less oral/intravenous pain medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | None available |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2008-09-19
- Last updated
- 2025-07-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00755989. Inclusion in this directory is not an endorsement.